Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thioaryl naphthylmethanone oxime ether analogs as novel anticancer agents.
Chakravarti B, Akhtar T, Rai B, Yadav M, Akhtar Siddiqui J, Dhar Dwivedi SK, Thakur R, Singh AK, Singh AK, Kumar H, Khan K, Pal S, Rath SK, Lal J, Konwar R, Trivedi AK, Datta D, Mishra DP, Godbole MM, Sanyal S, Chattopadhyay N, Kumar A. Chakravarti B, et al. Among authors: lal j. J Med Chem. 2014 Oct 9;57(19):8010-25. doi: 10.1021/jm500873e. Epub 2014 Sep 22. J Med Chem. 2014. PMID: 25198997
Novel Tetrahydroquinazolinamines as Selective Histamine 3 Receptor Antagonists for the Treatment of Obesity.
Kumar A, Pasam VR, Thakur RK, Singh M, Singh K, Shukla M, Yadav A, Dogra S, Sona C, Umrao D, Jaiswal S, Ahmad H, Rashid M, Singh SK, Wahajuddin M, Dwivedi AK, Siddiqi MI, Lal J, Tripathi RP, Yadav PN. Kumar A, et al. Among authors: lal j. J Med Chem. 2019 May 9;62(9):4638-4655. doi: 10.1021/acs.jmedchem.9b00241. Epub 2019 Apr 29. J Med Chem. 2019. PMID: 30998358
Induction of Mitochondrial Cell Death and Reversal of Anticancer Drug Resistance via Nanocarriers Composed of a Triphenylphosphonium Derivative of Tocopheryl Polyethylene Glycol Succinate.
Singh Y, Viswanadham KKDR, Pawar VK, Meher J, Jajoriya AK, Omer A, Jaiswal S, Dewangan J, Bora HK, Singh P, Rath SK, Lal J, Mishra DP, Chourasia MK. Singh Y, et al. Among authors: lal j. Mol Pharm. 2019 Sep 3;16(9):3744-3759. doi: 10.1021/acs.molpharmaceut.9b00177. Epub 2019 Aug 23. Mol Pharm. 2019. PMID: 31441308
Arylpiperazines for management of benign prostatic hyperplasia: design, synthesis, quantitative structure-activity relationships, and pharmacokinetic studies.
Sarswat A, Kumar R, Kumar L, Lal N, Sharma S, Prabhakar YS, Pandey SK, Lal J, Verma V, Jain A, Maikhuri JP, Dalela D, Kirti, Gupta G, Sharma VL. Sarswat A, et al. Among authors: lal n, lal j. J Med Chem. 2011 Jan 13;54(1):302-11. doi: 10.1021/jm101163m. Epub 2010 Dec 3. J Med Chem. 2011. PMID: 21128595
250 results